Skip to main content
. 2021 Oct 10;2:31. doi: 10.1186/s43556-021-00053-0

Fig. 6.

Fig. 6

Cell migration of prostate cancer cells treated with siCldn. The percent difference of (a) LNCaP and (b) PC3 prostate cancer cell scratch coverage between treatments (siCldn3, orange line and siCldn4, blue line) and control (siSC, black line) was determined at 6, 12, and 18 h. Data are shown as mean ± SD of 3 to 4 independent experiments where * represents p < 0.05